118 related articles for article (PubMed ID: 16041165)
1. Functional assessment by myocardial performance index (Tei index) correlates with plasma brain natriuretic peptide concentration in patients with hypertrophic cardiomyopathy.
Okawa M; Kitaoka H; Matsumura Y; Kubo T; Yamasaki N; Furuno T; Doi Y
Circ J; 2005 Aug; 69(8):951-7. PubMed ID: 16041165
[TBL] [Abstract][Full Text] [Related]
2. N-terminal pro-brain natriuretic peptide is related with coronary flow velocity reserve and diastolic dysfunction in patients with asymmetric hypertrophic cardiomyopathy.
Tesic M; Seferovic J; Trifunovic D; Djordjevic-Dikic A; Giga V; Jovanovic I; Petrovic O; Marinkovic J; Stankovic S; Stepanovic J; Ristic A; Petrovic M; Mujovic N; Vujisic-Tesic B; Beleslin B; Vukcevic V; Stankovic G; Seferovic P
J Cardiol; 2017 Oct; 70(4):323-328. PubMed ID: 28336204
[TBL] [Abstract][Full Text] [Related]
3. Significance of brain natriuretic peptide in the evaluation of symptoms and the degree of left ventricular diastolic dysfunction in patients with hypertrophic cardiomyopathy.
Panou FK; Kotseroglou VK; Lakoumentas JA; Chrysanthopoulou SA; Armeniakos JA; Stratigou T; Veve H; Zacharoulis AA
Hellenic J Cardiol; 2006; 47(6):344-51. PubMed ID: 17243506
[TBL] [Abstract][Full Text] [Related]
4. Doppler echocardiography-derived index of myocardial performance (TEI index): comparison with brain natriuretic peptide levels in various heart disease.
Ono M; Tanabe K; Asanuma T; Yoshitomi H; Shimizu H; Ohta Y; Shimada T
Jpn Circ J; 2001 Jul; 65(7):637-42. PubMed ID: 11446498
[TBL] [Abstract][Full Text] [Related]
5. [Correlation of B-type natriuretic peptide (NT-proBNP) levels and conventional and tissue Doppler echocardiographic parameters of left ventricular diastolic function in patients with hypertrophic cardiomyopathy].
Faludi R; Tóth L; Pótó L; Cziráki A; Simor T; Papp L
Orv Hetil; 2005 Jan; 146(1):23-6. PubMed ID: 15715369
[TBL] [Abstract][Full Text] [Related]
6. Neurohumoral profiles in patients with hypertrophic cardiomyopathy: differences to hypertensive left ventricular hypertrophy.
Ogino K; Ogura K; Kinugawa T; Osaki S; Kato M; Furuse Y; Kinugasa Y; Tomikura Y; Igawa O; Hisatome I; Shigemasa C
Circ J; 2004 May; 68(5):444-50. PubMed ID: 15118286
[TBL] [Abstract][Full Text] [Related]
7. Increased plasma brain natriuretic peptide level as a guide for silent myocardial ischemia in patients with non-obstructive hypertrophic cardiomyopathy.
Nakamura T; Sakamoto K; Yamano T; Kikkawa M; Zen K; Hikosaka T; Kubota T; Azuma A; Nishimura T
J Am Coll Cardiol; 2002 May; 39(10):1657-63. PubMed ID: 12020494
[TBL] [Abstract][Full Text] [Related]
8. Ventricular expression of brain natriuretic peptide in hypertrophic cardiomyopathy.
Hasegawa K; Fujiwara H; Doyama K; Miyamae M; Fujiwara T; Suga S; Mukoyama M; Nakao K; Imura H; Sasayama S
Circulation; 1993 Aug; 88(2):372-80. PubMed ID: 8339400
[TBL] [Abstract][Full Text] [Related]
9. Plasma amino-terminal pro-B-type natriuretic peptide quantification in hypertrophic cardiomyopathy.
Arteaga E; Araujo AQ; Buck P; Ianni BM; Rabello R; Mady C
Am Heart J; 2005 Dec; 150(6):1228-32. PubMed ID: 16338263
[TBL] [Abstract][Full Text] [Related]
10. Wall stress modulates brain natriuretic peptide production in pressure overload cardiomyopathy.
Vanderheyden M; Goethals M; Verstreken S; De Bruyne B; Muller K; Van Schuerbeeck E; Bartunek J
J Am Coll Cardiol; 2004 Dec; 44(12):2349-54. PubMed ID: 15607397
[TBL] [Abstract][Full Text] [Related]
11. Plasma adiponectin levels and left ventricular remodeling in hypertrophic cardiomyopathy.
Kitaoka H; Kubo T; Okawa M; Yamasaki N; Matsumura Y; Nishinaga M; Doi YL
Int Heart J; 2010 Jan; 51(1):51-5. PubMed ID: 20145352
[TBL] [Abstract][Full Text] [Related]
12. Correlation of the myocardial performance index with plasma B-type natriuretic peptide levels in patients with mitral regurgitation.
Sayar N; Lütfullah Orhan A; Cakmak N; Yilmaz H; Atmaca H; Tangürek B; Hasdemir H; Nurkalem Z; Ergelen M; Aksu H; Yeşilçimen K
Int J Cardiovasc Imaging; 2008 Feb; 24(2):151-7. PubMed ID: 17541723
[TBL] [Abstract][Full Text] [Related]
13. Incremental value of left ventricular diastolic function reserve index for predicting exercise capacity in patients with hypertrophic cardiomyopathy.
Choi EY; Ha JW; Rim SJ; Kim SA; Yoon SJ; Shim CY; Kim JM; Jang Y; Chung N; Cho SY
J Am Soc Echocardiogr; 2008 May; 21(5):487-92. PubMed ID: 17904804
[TBL] [Abstract][Full Text] [Related]
14. Relationship between the tissue Doppler-derived Tei index and plasma brain natriuretic peptide levels in patients with mitral regurgitation.
Kargin R; Esen O; Akçakoyun M; Pala S; Candan O; Omaygenç MO; Dogan C; Barutçu I; Esen AM; Ozdemir N
J Heart Valve Dis; 2010 Jan; 19(1):35-42. PubMed ID: 20329488
[TBL] [Abstract][Full Text] [Related]
15. [The myocardial performance index (Tei-Index): correlation with seric NTproBNP levels in patients with dilated cardiomyopathy].
Miclăuş S; Mornoş C; Maximov D; Lupu A; Popa D; Puşchiţă M
Rev Med Chir Soc Med Nat Iasi; 2009; 113(2):391-6. PubMed ID: 21495343
[TBL] [Abstract][Full Text] [Related]
16. Impairments of myocardial sympathetic activity may reflect the progression of myocardial damage or dysfunction in hypertrophic cardiomyopathy.
Matsuo S; Nakamura Y; Tsutamoto T; Kinoshita M
J Nucl Cardiol; 2002; 9(4):407-12. PubMed ID: 12161717
[TBL] [Abstract][Full Text] [Related]
17. Tei-index in patients with mild-to-moderate congestive heart failure.
Bruch C; Schmermund A; Marin D; Katz M; Bartel T; Schaar J; Erbel R
Eur Heart J; 2000 Nov; 21(22):1888-95. PubMed ID: 11052862
[TBL] [Abstract][Full Text] [Related]
18. Usefulness of N-terminal pro-B-type natriuretic peptide levels to predict exercise capacity in hypertrophic cardiomyopathy.
Thaman R; Esteban MT; Barnes S; Gimeno JR; Mist B; Murphy R; Collinson PO; McKenna WJ; Elliott PM
Am J Cardiol; 2006 Aug; 98(4):515-9. PubMed ID: 16893708
[TBL] [Abstract][Full Text] [Related]
19. B-type natriuretic peptide predicts disease severity in children with hypertrophic cardiomyopathy.
Kaski JP; Tomé-Esteban MT; Mead-Regan S; Pantazis A; Marek J; Deanfield JE; McKenna WJ; Elliott PM
Heart; 2008 Oct; 94(10):1307-11. PubMed ID: 18070943
[TBL] [Abstract][Full Text] [Related]
20. Usefulness of B-type natriuretic peptide assay in the assessment of symptomatic state in hypertrophic cardiomyopathy.
Maron BJ; Tholakanahalli VN; Zenovich AG; Casey SA; Duprez D; Aeppli DM; Cohn JN
Circulation; 2004 Mar; 109(8):984-9. PubMed ID: 14967727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
